Key terms
About CARM
Carisma Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery and development of immunotherapies. It offers chimeric antigen receptor (CAR)-macrophages, a cell therapy platform focusing on the treatment of solid tumors. The company was founded by Michael Klichinsky and Saar Gill in 2016 and is headquartered in Philadelphia, PA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest CARM news
Dec 15
6:29am ET
Innovative CAR-M Therapy Advancements Fuel Buy Rating for Carisma Therapeutics
Dec 14
7:05am ET
Carisma Therapeutics nominates first lead candidate in Moderna collaboration
Nov 06
6:30am ET
Analysts Offer Insights on Healthcare Companies: BioCryst (BCRX), Cidara Therapeutics (CDTX) and Carisma Therapeutics (CARM)
No recent news articles are available for CARM
No recent press releases are available for CARM
CARM Financials
Key terms
Ad Feedback
CARM Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
CARM Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range